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Objectives
The aim of this randomized controlled trial (RCT) was to test 
whether a sage-based mouthwash improves Oral Health-Related 
Quality of Life (OHRQoL) and xerostomia-related symptoms com-
pared to a placebo. 
Methods
This study was ethics approved (Basec-Nr.: 2016-01383) and regis-
tered (clinicaltrials.gov: NCT0283080). Potential subjects (inclusion: 
≥65 years, dentate) from private practice and long-term-care 
facilities were included in this randomized, double-blind, placebo-
controlled, parallel, clinical trial. Participants were randomly allo- 
cated into either group A (active agent, Dr. Hauschka Med Mund-
spülung Salbei, WALA Heilmittel GmbH, Bad Boll/Eckwälden, Germa-
ny; Fig. 1) or group B (taste and color matched custom-fabricated 
water/alcohol-based placebo). 
The mouthwash was used once a day for 30 seconds in addition 
to performing the usual oral hygiene measures, for an intervention 
period of six weeks. The primary endpoints were the evaluation of 
OHRQoL and the xerostomia-related impairments using the 14-item 
German versions of the Oral Health Impact Profile (OHIP-14) and 
Xerostomia Inventory (XI, 14 items). Linear regression models were 
applied for the statistical analysis (alpha = 0.05).  
Results
Forty-eight subjects were included in the study (mean age = 77.5±7.3 
years). Forty-two participants completed the trial and were included 
for the data analysis (excluded: n = 6, group A = 3, group B = 3; 
reason for exclusion: incomplete data). 
Results of linear regression analysis of intervention effect on OHIP-14 
and XI summary scores at follow-up, statistically controlled for base-
line scores revealed no effect of the intervention (p = 0.521 and 
p = 0.379, respectively; Tabs. 1 + 2). The XI summary score was 
highly correlated to the OHIP-14 summary score at baseline and at 
follow-up (Pearson product moment correlation coefficients: 0.55 
and 0.60).
Conclusions
The findings of this study do not indicate that the sage-based mouthwash was better than the placebo in improving the OHRQoL 
and the xerostomia-related impairments. The results indicate a sufficient convergent validity of the XI to assess a person’s OHRQoL 
impairments due to xerostomia.
Figure 1: Evaluated sage-based mouthwash (active agent; Group A)
Table 1: OHIP-14 summary scores at baseline and follow-up for both groups with  
corresponding differences
Table 2: XI summary scores at baseline and follow-up for both groups with  
corresponding differences
#0799
Baseline Follow-up Diff
Mean (SD) Mean (CI) p-value Effect size
Intervention 0.7 (2.2) 0.5 (1.4) 0.2 (–0.3; 0.7) .463 0.10
Control 1.4 (2.1) 1.0 (1.7) 0.4 (–0.8; 1.6) .462 0.22
Baseline Follow-up Diff
Mean (SD) Mean (CI) p-value Effect size
Intervention 8.9 (11.4) 10.7 (10.0) 1.8 (–0.5; 4.1) .115 0.17
Control 7.7 (6.2) 8.2 (10.4) 0.5 (–1.7; 2.6) .652 0.06
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